Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer's disease.
about
Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical ADUshering in the study and treatment of preclinical Alzheimer diseaseAlzheimer's disease: Unique markers for diagnosis & new treatment modalitiesBrain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's diseaseF-spondin gene transfer improves memory performance and reduces amyloid-β levels in mice.Conformation-dependent oligomers in cerebrospinal fluid of presymptomatic familial Alzheimer's disease mutation carriers.Fluid biomarkers in Alzheimer's disease - current conceptsMetabolic profiling of Alzheimer's disease brainsEarly behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network.Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid.Biomarkers in Sporadic and Familial Alzheimer's Disease.A cross-sectional study on cerebrospinal fluid biomarker levels in cognitively normal elderly subjects with or without a family history of Alzheimer's disease.Clinical use of cerebrospinal fluid biomarkers in Alzheimer's disease.Fluid biomarkers for Alzheimer's disease: standardization and recent developments.Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease.
P2860
Q26801666-DDC98280-3792-43A0-85A3-9A0FE23FE818Q27014791-4413A471-B30E-4ACE-AD1A-E5E08C0D5AA2Q28085139-497A1CAE-40B8-4FF2-833F-759B5CC00A76Q34274231-F32E4625-14BA-45A3-905D-B254DC07815EQ35284971-9A639629-4434-435D-A24B-5DE55D415816Q36317638-4ED5D2A7-7D90-45C3-95E7-0A0519502E31Q36551476-C52DFFD3-768B-4D27-9CC6-2AB6AF99D20EQ36953503-C6AF541D-F3E5-49F8-BBA8-AD62FEB59C41Q37072582-56C801F1-D3EC-47C4-B677-7FCE76BCF8A4Q37132846-47B7C557-2036-4779-8F90-A55A10F72A2FQ38113683-CA552FF7-16E2-4EC4-951D-2D843B55A865Q38592041-B4B0D315-8080-45F8-AE8C-08DB545351FFQ46142593-606BB04C-6F9E-45CD-B0B5-E4F220A16D7CQ48400950-F287E97F-0A6D-4B4B-B918-998FB0763FE3Q53332005-D85F016C-C81D-4039-9DCB-1A717B38DFEDQ53481618-2A97E50B-D69C-4ACA-9FA3-2AEE5E9C1622
P2860
Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cerebrospinal fluid biomarkers ...... familial Alzheimer's disease.
@en
type
label
Cerebrospinal fluid biomarkers ...... familial Alzheimer's disease.
@en
prefLabel
Cerebrospinal fluid biomarkers ...... familial Alzheimer's disease.
@en
P2093
P2860
P921
P356
P1476
Cerebrospinal fluid biomarkers ...... familial Alzheimer's disease.
@en
P2093
David Elashoff
Giovanni Coppola
Greg M Cole
John M Ringman
Karen Gylys
Luis D Medina
Yaneth Rodriguez-Agudelo
P2860
P356
10.1159/000335729
P577
2012-02-13T00:00:00Z